Enhancement of adaptive immune responses by post-inoculation administration of fenretinide (N-(4-hydroxyphenyl)retinamide)
This technology uses fenretinide, a synthetic vitamin A derivative, to boost the body’s adaptive immune response after vaccination or infection, making vaccines more effective, especially for poorly immunogenic agents or immunocompromised individuals, without increasing infection severity.
Background:
The field of vaccine development and immunotherapy...
Published: 5/29/2026
|
Inventor(s): Adam Waickman, Stephen Thomas, David Foster, Herbert Slade
Keywords(s): Technologies, vaccine stability, vaccines
Category(s): Campus > Upstate Medical University, Technology Classifications > Therapeutics and Vaccines
|